Literature DB >> 9392834

Elevated neuropeptide Y gene expression and release during hypoglycemic stress.

S Han1, X Chen, Y M Wu, L Naes, T Westfall.   

Abstract

Our previous studies show that neuropeptide Y (NPY) is involved in mediating sympathetic nerve stimulation-induced vasoconstriction. Insulin hypoglycemia is known to produce increased sympathetic output and elevated arterial pressure. The present study examined the role of NPY in the hypertensive response to insulin by examining the effects of insulin on NPY gene expression, tissue content and release. Subcutaneous injection of insulin produced an immediate increase in plasma NPY immunoreactivity (NPYir) and delayed increases in adrenal and neuronal NPY mRNA and adrenal NPYir in rats. These results suggest that NPY may play a role in insulin-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392834     DOI: 10.1016/s0196-9781(97)00212-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  Rethinking the role of the brain in glucose homeostasis and diabetes pathogenesis.

Authors:  Jenny M Brown; Jarrad M Scarlett; Michael W Schwartz
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

2.  AgRP-Expressing Adrenal Chromaffin Cells Are Involved in the Sympathetic Response to Fasting.

Authors:  Rajesh Gupta; Yunbing Ma; Manqi Wang; Matthew D Whim
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

3.  The role of neuropeptide Y in the ovine fetal cardiovascular response to reduced oxygenation.

Authors:  Emilia M Sanhueza; Anja A Johansen-Bibby; Andrew J W Fletcher; Raquel A Riquelme; Alejandro J Daniels; Maria Serón-Ferré; Cristián R Gaete; Jorge E Carrasco; Aníbal J Llanos; Dino A Giussani
Journal:  J Physiol       Date:  2003-02-01       Impact factor: 5.182

4.  Modulation of tyrosine hydroxylase, neuropeptide y, glutamate, and substance p in Ganglia and brain areas involved in cardiovascular control after chronic exposure to nicotine.

Authors:  Merari F R Ferrari; Emerson F Coelho; Karen L G Farizatto; Gerson Chadi; Debora R Fior-Chadi
Journal:  Int J Hypertens       Date:  2011-07-31       Impact factor: 2.420

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.